Radiopharm Theranostics and SHINE Technologies Announce Clinical Supply Agreement for Cancer-Fighting Medical Isotope ...Middle East

PR Newswire - News
Radiopharm Theranostics and SHINE Technologies Announce Clinical Supply Agreement for Cancer-Fighting Medical Isotope
SHINE to supply n.c.a. lutetium-177 for the clinical development of multiple programs for Radiopharm Theranostics JANESVILLE, Wis. and SYDNEY, Sept. 19, 2022 /PRNewswire/ -- SHINE Technologies, a next-generation fusion technology company, and Radiopharm Theranostics (ASX:RAD), a developer...

Hence then, the article about radiopharm theranostics and shine technologies announce clinical supply agreement for cancer fighting medical isotope was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Radiopharm Theranostics and SHINE Technologies Announce Clinical Supply Agreement for Cancer-Fighting Medical Isotope )

Apple Storegoogle play

Last updated :

Also on site :